Evidence-based medicine

Bioventus to Present at the Morgan Stanley Global Healthcare Conference

Retrieved on: 
Tuesday, August 30, 2022
Twitter, Innovation, GLOBE, Evidence-based medicine, Conference, Physician, Nasdaq, Company, LinkedIn, Patient, Hospital

DURHAM, N.C., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice-president and chief financial officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2022, at 11:10 a.m.

Key Points: 
  • DURHAM, N.C., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice-president and chief financial officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2022, at 11:10 a.m.
  • The Innovations for Active Healing from Bioventus include offerings for pain treatment, restorative therapies and surgical solutions.
  • Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.
  • Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Hillsdale College Academy for Science and Freedom Releases Statement on “Ethical Principles of Public Health”

Retrieved on: 
Friday, August 26, 2022
Education, Health, General Health, Research, Science, University, COVID-19, The Heritage Foundation, Ethics, Academy, Stanford University School of Medicine, Degenerative disease, Stanford Institute for Economic Policy Research, Atlas, Bioethics, Stanford University, University of Oxford, Fellow, Education, Université de Namur, College, Evidence-based medicine, Student, Economics, Public, Catholic higher education, Demography, Lille Catholic University, Edmund S. Muskie Internship Program, Hoover Institution, Hillsdale College, Curriculum, Medical ethics, SIEPR, Â, Economic Policy (journal), University, Public health, Ethics and Public Policy Center, Harvard University, Council of Senior Scholars (Saudi Arabia), Public relations, Pharmaceutical industry, Management, Medicine, Imprimis, Science, Ageing, D.C, Medicine, Health policy, American, Health

The Academy for Science and Freedom at Hillsdale College has released a statement entitled Ethical Principles of Public Health.

Key Points: 
  • The Academy for Science and Freedom at Hillsdale College has released a statement entitled Ethical Principles of Public Health.
  • The statement, coauthored by a dozen prominent medical science, public health, and biomedical ethics experts from around the world, outlines the necessary conditions for a humane and effective response to a national public health crisis.
  • The 10-point statement was written by the Academy for Science and Freedom in collaboration with several national and international experts in the medical sciences and related fields.
  • Hillsdale College established the Academy for Science and Freedom to combat the recent and widespread abuses of individual and academic freedom made in the name of science.

CCGroup Clinical Decision Support System Quantifies “COVID Effect” on Decreased Healthcare Utilization in the United States

Retrieved on: 
Thursday, August 25, 2022
Software, Practice Management, General Health, Health, COVID-19, Consulting, Professional Services, Technology, PCP, Software, CDSS, Evidence-based medicine, Time, CCgroup, Cave, Physician, Hospital, TPA-023, Command Consulting Group, Health maintenance organization, FFS, COVID, Efficiency, Medicine, Medical device, Pharmaceutical industry, Medicare

Cave Consulting Group, Inc. (CCGroup) initiated this study to quantify the COVID Effects impact on decreased U.S. healthcare utilization.

Key Points: 
  • Cave Consulting Group, Inc. (CCGroup) initiated this study to quantify the COVID Effects impact on decreased U.S. healthcare utilization.
  • We examine here only the initial component, decreased volume of medical condition episodes, stated Dr. Douglas Cave , President of CCGroup.
  • Acute versus chronic medical condition episode volume:
    Dr. Cave stated, We used the Cave Grouper and CCGroup Clinical Decision Support System (CDSS) to quantify the COVID Effect.
  • A clinical row is comprised of a medical condition, an associated MedMarker, and an established Clinical MedMarker Protocol Range.

NantHealth’s Eviti Platform Once More Earns Full URAC Accreditation Through 2025

Retrieved on: 
Wednesday, August 24, 2022
Software, Internet, Professional Services, Oncology, Data Management, Apps, Applications, Technology, Health Technology, Health Insurance, Data Analytics, Practice Management, Health, Patient safety, CEO, Technology, Accreditation, Evidence-based medicine, Telecommunication, NASDAQ, YouTube, Solution, Pharmacy, NantWorks, Sound, LinkedIn, Blog, Education, Organization, URAC, Leadership, Compliance, Twitter, Business Integration Group, Inc., NantHealth, Health, Patient, Health insurance, Hospital, Facebook

This latest recognition extends URAC accreditation through September 1, 2025.

Key Points: 
  • This latest recognition extends URAC accreditation through September 1, 2025.
  • The URAC accreditation process validates compliance with nationally recognized, evidence-based standards and supports improvements and innovation in healthcare management and delivery.
  • "NantHealth is honored to have attained full reaccreditation from URAC for Health Utilization Management," said Ron Louks, NantHealths chief operating officer.
  • URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability.

Accident Fund Improves Injured Worker Outcomes With CLARA Analytics

Retrieved on: 
Monday, August 22, 2022
Technology, Insurance, Professional Services, Software, Managed Care, Health, Data Analytics, Data Management, Artificial Intelligence, Accident Fund, CEO, Technology, Evidence-based medicine, Artificial intelligence, Insurance, Solution, AF, Culture, CLARA, LinkedIn, AF Group, Quality of life, Natural language processing, Twitter, Silicon, Risk, Name, AIAA Journal, AI

The company will initially deploy CLARA Treatment at Accident Fund , an AF Group brand specializing in workers compensation insurance for small- to mid-sized businesses.

Key Points: 
  • The company will initially deploy CLARA Treatment at Accident Fund , an AF Group brand specializing in workers compensation insurance for small- to mid-sized businesses.
  • CLARA Analytics aligns nicely with that strategy helping injured employees recover quickly while also minimizing losses for policyholders and improving our claims management processes.
  • AF Group has been remarkably innovative in their use of data analytics to foster a culture of underwriting and claims excellence, said Heather H. Wilson, CEO of CLARA Analytics.
  • CLARA Analytics is the leading AI as a service (AIaaS) provider that improves casualty claims outcomes for commercial insurance carriers and self-insured organizations.

North American Partners in Anesthesia brings concierge anesthesia services to Wilmington Health ASC

Retrieved on: 
Tuesday, August 16, 2022
Multimedia, Pain management, Ear, NAPA, Doctor of Nursing Practice, Hospital, Crna, Communication, True Care, 3D ultrasound, Obstetrics, Patient, Gynaecology, Nose, Trust, Evidence-based medicine, Physician, Solution, Efficiency, Medicine, Anesthesia, MD

MELVILLE, N.Y., Aug. 16, 2022 /PRNewswire/ -- North American Partners in Anesthesia (NAPA) is the new outpatient anesthesia services provider for Wilmington Health Ambulatory Surgery Center (Wilmington Health ASC).

Key Points: 
  • MELVILLE, N.Y., Aug. 16, 2022 /PRNewswire/ -- North American Partners in Anesthesia (NAPA) is the new outpatient anesthesia services provider for Wilmington Health Ambulatory Surgery Center (Wilmington Health ASC).
  • Wilmington Health ASC is located at 1305 Glen Meade Road, Wilmington, NC, 28401, and is part of Wilmington Health, a large multi-specialty physician-owned practice.
  • Robert Colon, ASC Administrator, Wilmington Health ASC, said, "We are pleased to have NAPA's highly skilled clinicians providing anesthesia services for our preventive, diagnostic, and therapeutic procedures.
  • As a clinician-led organization, North American Partners in Anesthesia (NAPA) is redefining healthcare,delivering unsurpassed excellence to its partners and patients every day.

SANUWAVE Health Reports Second Quarter 2022 Financial Results & Will Host Live Conference Call With Business Update 

Retrieved on: 
Monday, August 15, 2022
U.S. Securities and Exchange Commission, Prairie, CEO, Forward-looking statement, GLOBE, Growth, Private Securities Litigation Reform Act, SEC, Regenerative medicine, Security (finance), Research, Regeneration, Health, Marketing, Company, Skin, OTC, Operating cost, Evidence-based medicine, Wound healing, EDT, Time, Online gambling

Eden Prairie, MN, Aug. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, reported financial results for their second quarter ending June 30, 2022, with the SEC on Friday, August 12, 2022.

Key Points: 
  • Eden Prairie, MN, Aug. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, reported financial results for their second quarter ending June 30, 2022, with the SEC on Friday, August 12, 2022.
  • The Company will host a live conference call on Tuesday, August 16, 2022, at 12:30 (EDT) to provide a business update (Dial-in information below).
  • Disruption from this process flow issue led to late filings, which led to our issues on the OTC and Pink Sheets.
  • SANUWAVE Health, Inc. will host a live conference call on Tuesday, August 16, 2022, at 12:30 (EDT) to discuss recent business activity, provide an update on SEC filings, and detail strategic initiatives.

AvoMD Strengthens Its Advisory Board with Appointment of Mark Clermont, CEO of Cecelia Health, and former CFO of UpToDate and Wolters Kluwer Health

Retrieved on: 
Monday, August 8, 2022
BNY Mellon, Kidney disease, Adoption, Multimedia, CEO, Algorithm, CFO, American Academy, UpToDate, Technology, Sale, American Academy of Family Physicians, Society of Cardiovascular Computed Tomography, EHR, Hospital, Web browser, Knowledge, Wolters Kluwer, Patient, Acquisition, Society, Mercer, Advisory board, Evidence-based medicine, Population health, Time, The Advisory Board Company, Quest Diagnostics, Management, Pharmaceutical industry, Finance

Mark joins AvoMD as the company accelerates its efforts to bring expert, society-based guidelines to the bedside.

Key Points: 
  • Mark joins AvoMD as the company accelerates its efforts to bring expert, society-based guidelines to the bedside.
  • A free version of AvoMD can be accessed via web browser , mobile app , and the electronic health record .
  • AvoMD Cofounder and CEO, Dr. Yair Saperstein, commented: "Mark's decision to join our Advisory Board marks a new chapter for AvoMD.
  • Post-acquisition, Mark served as the CFO and Vice President of Finance of Wolters Kluwer Health.

SANUWAVE Appoints New Board Chairman

Retrieved on: 
Monday, August 8, 2022
Movement, Intellectual property, U.S. Securities and Exchange Commission, CEO, Forward-looking statement, GLOBE, Lip, Private Securities Litigation Reform Act, Growth, Leadership, Regenerative medicine, Board, Security (finance), Research, Regeneration, Health, Marketing, Company, Skin, NASDAQ, Evidence-based medicine, Wound healing, Economics

SUWANEE, GA, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, is pleased to announce the appointment of Mr. Morgan C. Frank as new Board Chairman effectivetoday, August 5, 2022.

Key Points: 
  • SUWANEE, GA, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, is pleased to announce the appointment of Mr. Morgan C. Frank as new Board Chairman effectivetoday, August 5, 2022.
  • He currently sits on the board of directors of Modular Medical (MODD) a development stage insulin delivery company.Mr.
  • When asked about the new opportunity Mr. Frank states, It is an honor to step into the role of Chairman at SANUWAVE.
  • SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.

Bioventus Receives FDA 510(k) Clearance for SonaStar Elite  

Retrieved on: 
Wednesday, August 3, 2022
Innovation, Twitter, Projection, U.S. Securities and Exchange Commission, Neurosurgery, Nasdaq, Terminology, LinkedIn, Malignancy, Risk, Physician, US Foods, SEC, Security (finance), History, Patient, Failure, SSE, Neoplasm, GLOBE, Forward-looking statement, Review, Research, Food, FDA, COVID-19, Investment, Evidence-based medicine, Company, Surgeon, NEXUS, Government, Medical imaging

DURHAM, N.C., Aug. 03, 2022 (GLOBE NEWSWIRE) --  Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced the US Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s neXus® SonaStar Elite® handpiece. The SonaStar Elite (SSE) handpiece is powered by the neXus Ultrasonic Surgical Aspirator System, a next generation integrated ultrasonic surgical platform driven by a proprietary digital algorithm resulting in more versatility and control. The neXus system combines all the features of soft and hard (including bone) tissue removal into a single fully integrated platform capable of operating at multiple frequencies, including the newly approved 36 kHz SonaStar Elite Handpiece.

Key Points: 
  • DURHAM, N.C., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, announced the US Food and Drug Administration (FDA) has granted 510(k) clearance for the companys neXus SonaStar Elite handpiece.
  • The SonaStar Elite (SSE) handpiece is powered by the neXus Ultrasonic Surgical Aspirator System, a next generation integrated ultrasonic surgical platform driven by a proprietary digital algorithm resulting in more versatility and control.
  • "The SonaStar Elite handpiece is the latest innovation in our neXus ultrasonic surgical pipeline," commented Andrew Hosmer, general manager, Surgical Solutions, at Bioventus.
  • Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.